System and method for treating valve insufficiency or vessel dilatation

US9289282B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9289282-B2
Application numberUS-201213485358-A
CountryUS
Kind codeB2
Filing dateMay 31, 2012
Priority dateMay 31, 2011
Publication dateMar 22, 2016
Grant dateMar 22, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medical device for treating aortic insufficiency (and associated aneurysms or defects of any other vessel associated with a valve) includes a support structure, a stent, a prosthetic valve and a deflector. Generally, the support structure is configured to cooperate with the prosthetic valve to pinch the native valve therebetween and provide an anchor for the stent which extends into the aorta and supports the deflector which is positioned to abate blood flow against the aneurysm.

First claim

Opening claim text (preview).

What is claimed: 1. A medical device for use in a heart having a native heart valve and a vessel extending from the native heart valve, the medical device comprising: a support structure; a stent, separate from the support structure, configured to couple to the support structure using a plurality of retaining arms and extend from the support structure into the vessel; a prosthetic heart valve configured for implantation in the native heart valve without a direct coupling to the support structure or the stent; and a deflector configured to be supported by the stent and abate blood flow against the vessel; wherein the support structure is configured to extend around the leaflets of the native heart valve and wherein the leaflets of the native heart valve are pinched between the prosthetic heart valve and the support structure after implantation. 2. The medical device of claim 1 , wherein the stent has openings configured for placement adjacent arteries extending from the vessel. 3. The medical device of claim 1 , wherein the deflector is configured to expand to fill at least a portion of a space defined between an external surface of the stent and the vessel. 4. The medical device of claim 3 , wherein the deflector includes a foam. 5. The medical device of claim 4 , wherein the foam is configured for 300% compression. 6. The medical device of claim 5 , wherein a compressed diameter of the foam and stent is 8 mm or less. 7. The medical device of claim 6 , wherein an uncompressed diameter of the foam and stent is 50 mm to 90 mm. 8. The medical device of claim 1 , further comprising one or more mechanical clot facilitators configured for placement between the deflector and the vessel. 9. The medical device of claim 1 , wherein the prosthetic heart valve is balloon-expandable. 10. The medical device of claim 1 , wherein the support structure comprises an undulating ring. 11. A medical device for use in a heart having a heart valve and a vessel associated with the heart valve, the medical device comprising: a support structure configured to engage the heart valve, the support structure comprising an undulating ring; a stent configured to couple to the support structure and extend from the support structure into the vessel; and a foam deflector configured to be supported by the stent and abate blood flow against the vessel, wherein an uncompressed diameter of the foam deflector and stent is 50 mm to 90 mm; a prosthetic heart valve configured for implantation in the native heart valve wherein the prosthetic heart valve is balloon-expandable.

Assignees

Inventors

Classifications

  • with soft flexible valve members, e.g. tissue valves shaped like natural valves · CPC title

  • swellable · CPC title

  • V-shaped · CPC title

  • made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes · CPC title

  • Support rings therefor, e.g. for connecting valves to tissue (annuloplasty rings A61F2/2442) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9289282B2 cover?
A medical device for treating aortic insufficiency (and associated aneurysms or defects of any other vessel associated with a valve) includes a support structure, a stent, a prosthetic valve and a deflector. Generally, the support structure is configured to cooperate with the prosthetic valve to pinch the native valve therebetween and provide an anchor for the stent which extends into the aorta…
Who is the assignee on this patent?
Olson Christopher, Rabito Glen T, Armer Dustin P, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61F2/07. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).